Alan Sandler
Director/Board Member chez ELEVATION ONCOLOGY, INC.
Fortune : 76 117 $ au 31/03/2024
Profil
Alan Bart Sandler is currently an Independent Director at Elevation Oncology, Inc. and the President of American Pacific Core, Inc. Previously, he served as the Chief Medical Officer & Executive Vice President at Mirati Therapeutics, Inc. from 2022 to 2024, and as the Head-Global Development & Oncology at Zai Lab Ltd.
from 2020 to 2022.
He obtained his undergraduate degree from the University of Toledo (Ohio) and his doctorate from Rush Medical College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ZAI LAB LTD.
0,00% | 17/04/2023 | 46 180 ( 0,00% ) | 76 117 $ | 31/03/2024 |
ELEVATION ONCOLOGY, INC.
-.--% | 29/02/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Alan Sandler
| Sociétés | Poste | Début |
|---|---|---|
| ELEVATION ONCOLOGY, INC. | Director/Board Member | 04/03/2024 |
American Pacific Core, Inc.
 American Pacific Core, Inc. Specialty StoresRetail Trade American Pacific Core, Inc. wholesales auto parts in the United States. It offers power sources, combustion engine components, non electric motors, generator components and engines. The company was founded in 1982 and is headquartered in Santa Ana, CA. | President | 30/09/2010 |
Anciens postes connus de Alan Sandler
| Sociétés | Poste | Fin |
|---|---|---|
| MIRATI THERAPEUTICS | Chief Tech/Sci/R&D Officer | 23/01/2024 |
| ZAI LAB LIMITED | Corporate Officer/Principal | 28/10/2022 |
Formation de Alan Sandler
| University of Toledo (Ohio) | Undergraduate Degree |
| Rush Medical College | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ZAI LAB LIMITED | Health Technology |
| Entreprise privées | 3 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
| Elevation Oncology, Inc. | |
American Pacific Core, Inc.
American Pacific Core, Inc. Specialty StoresRetail Trade American Pacific Core, Inc. wholesales auto parts in the United States. It offers power sources, combustion engine components, non electric motors, generator components and engines. The company was founded in 1982 and is headquartered in Santa Ana, CA. | Retail Trade |
